Genome-wide in vivo CRISPR screen identifies TGFbeta3 as actionable biomarker of palbociclib resistance in triple negative breast cancer.

Poulet S, Dai M, Wang N, Yan G, Boudreault J, Daliah G, Guillevin A, Nguyen H, Galal S, Ali S, Lebrun JJ
Mol Cancer. 2024 Jun 3;23(1):118. doi: 10.1186/s12943-024-02029-4. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.